Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation-Reference-Cited by-同舟云学术

Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation

Published:2019-11-30 Issue:6 Volume:60 Page:1315-1320
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Aoyama Daisetsu¹,Miyazaki Shinsuke¹,Hasegawa Kanae¹,Kaseno Kenichi¹,Ishikawa Eri¹,Mukai Moe¹,Miyahara Kosuke¹,Aiki Takayoshi¹,Matsui Akira¹,Yamaguchi Junya¹,Shiomi Yuichiro¹,Tama Naoto¹,Ikeda Hiroyuki¹,Fukuoka Yoshitomo¹,Morishita Tetsuji¹,Ishida Kentaro¹,Uzui Hiroyasu¹,Tada Hiroshi¹

Affiliation:

1. Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/60/6/60_19-143/_pdf

Reference15 articles.

1. 1. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. J Arrhythm 2017; 33: 369-409.

2. 2. Di Biase L, Burkhardt JD, Santangeli P, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. Circulation 2014; 129: 2638-44.

3. 3. Takayama K, Hachiya H, Iesaka Y, Hirao K, Isobe M. Early recurrence after longstanding persistent atrial fibrillation ablation. Int Heart J 2018; 59: 321-7.